A small number of studies have found that SLPI can be involved in the progression of ovarian cancer by regulating ERK MAPK signaling pathway 27, and it can also be involved in myocardial ischemia/reperfusion injury by regulating the p38 MAPK signaling pathway 28. The gene discussed is SLPI; the disease is ovarian carcinoma.